The Predictive Value of Inflammation at Ileocecal Resection Margins for Postoperative Crohn's Recurrence: A Cohort

Karin A T G M Wasmann1, Jojanneke van Amesfoort1,2, Maurits L van Montfoort2

  • 1Dept. of surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Inflammatory Bowel Diseases
|December 28, 2019
PubMed
Abstract

Insights

Microscopic active inflammation at the distal colonic resection margin after Crohn's disease surgery predicts recurrence. This finding helps identify high-risk patients for more intensive medical treatment and guides surgical pathology practices.

Area of Science:

  • Gastroenterology
  • Surgical Pathology
  • Inflammatory Bowel Disease Research

Background:

  • Crohn's disease resections aim to remove only macroscopically affected bowel.
  • Microscopic inflammation at resection margins may predict postoperative recurrence, but clinical impact is unclear due to varied pathological criteria.

Purpose of the Study:

  • To assess the predictive value of pathological characteristics at ileocecal resection margins for Crohn's disease recurrence.

Main Methods:

  • 106 patients undergoing ileocecal resection for Crohn's disease had resection margins revised and scored for inflammation, myenteric plexitis, and granulomas.
  • Pathological findings were correlated with recurrence using multivariate analysis, defining recurrence as endoscopic evidence of disease activity requiring increased medical treatment.

Main Results:

  • Active inflammation was present in 27% (proximal) and 15% (distal) margins; myenteric plexitis in 37% (proximal) and 32% (distal); granulomas in 4% (proximal) and 6% (distal).
  • Active inflammation at the distal colonic resection margin independently predicted recurrence (88% recurrence with distal margin involvement vs. 43% proximal, 51% no involvement; P < 0.01).

Conclusions:

  • Active inflammation at the distal colonic resection margin after ileocecal resection identifies patients at high risk for recurrence.
  • This finding may indicate undiagnosed L3 disease and a more aggressive disease course, necessitating intensified medical treatment.
  • Pathological evaluation of the distal resection margin should be integrated into routine practice for Crohn's disease management.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
873
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
403
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
576
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
801
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
403
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
419